A Rabbit Osteomyelitis Model to Simulate Multibacterial War Wound Infections

Similar documents
Dual Antibiotic Delivery from Chitosan Sponges Prevents In Vivo Polymicrobial Biofilm Infections

TITLE: Polymicrobial Chronic Infection Including Acinetobacter baumannii in a Plated Segmental Defect in the Rat Femur

Microbiology of War Wounds AUBMC Experience

Experimental Osteomyelitis Treatment With Antibiotic-Impregnated Hydroxyapatite

Anti-infective Studies

Empirical Antibiotic Treatment of Disabled Veterans with Chronic Osteomyelitis

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

A Model for Chronic Osteomyelitis Using Staphylococcus aureus in Goats

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

against Clinical Isolates of Gram-Positive Bacteria

Le infezioni di cute e tessuti molli

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Appropriate antimicrobial therapy in HAP: What does this mean?

Summary of unmet need guidance and statistical challenges

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

Burn Infection & Laboratory Diagnosis

QUESTION 11: What is the relevance of Minimum Inhibitory Concentration (MIC) of infecting organisms in biofilm-mediated chronic infection?

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Orthopedic injuries constitute the majority of wounds

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Reducing Infections in Surgical Practice. Fred A Sweet, MD Rockford Spine Center Illinois, USA

Visit ABLE on the Web at:

General Approach to Infectious Diseases

Earlier Debridement and Antibiotic Administration Decrease Infection

New Drugs for Bad Bugs- Statewide Antibiogram

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Tel: Fax:

Bacteria Recovered from Patients Admitted to a Deployed U.S. Military Hospital in Baghdad, Iraq

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

What Is Thought To Be The Problem?

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Received 1 June 2010/Returned for modification 15 November 2010/Accepted 18 December 2010

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Principles of Antimicrobial Therapy

Intrinsic, implied and default resistance

Multidrug Resistant Bacteria in 200 Patients of Moroccan Hospital

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

DETERMINANTS OF TARGET NON- ATTAINMENT IN CRITICALLY ILL PATIENTS RECEIVING β-lactams

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya

Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Antimicrobial Cycling. Donald E Low University of Toronto

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

Scottish Medicines Consortium

Bacteriological Profile and Antimicrobial Sensitivity of Wound Infections

Antimicrobial Stewardship Strategy: Antibiograms

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: Oregon Health Plan

Evaluation of Carbohydrate-Derived Fulvic Acid (CHD-FA) as a Topical Broad-Spectrum Antimicrobial for Drug-Resistant Wound Infections.

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Isolation of MRSA from the Oral Cavity of Companion Dogs

Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

New Antibiotics for MRSA

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Surgical prophylaxis for Gram +ve & Gram ve infection

Bacterial infections complicating cirrhosis

Multi-Drug Resistant Organisms (MDRO)

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

Antibacterials. Recent data on linezolid and daptomycin

Testimony of the Natural Resources Defense Council on Senate Bill 785

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3

Other Beta - lactam Antibiotics

MRSA surveillance 2014: Poultry

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

GUIDELINE FOR ANTIMICROBIAL USE IN THE ORTHOPAEDIC AND TRAUMA DEPARTMENT

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

Why should we care about multi-resistant bacteria? Clinical impact and

MANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS

Isolation of Urinary Tract Pathogens and Study of their Drug Susceptibility Patterns

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

IT Clamp 50. Transforming the Field of Emergency Trauma Care

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

CHAPTER 1 INTRODUCTION

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

A Study on Bacterial Flora on the Finger printing Surface of the Biometric Devices at a Tertiary Care Hospital

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Bovine Mastitis Products for Microbiological Analysis

Transcription:

MILITARY MEDICINE, 178, 6:696, 2013 A Rabbit Osteomyelitis Model to Simulate Multibacterial War Wound Infections Li-Yan Yin, MD; Maurice M. Manring, PhD; Jason H. Calhoun, MD, FACS ABSTRACT A challenge facing military caregivers is the presence of multidrug-resistant infection in extremity wounds. Most frequently identified resistant strains are methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae (KP), Pseudomonas aeruginosa (PA), and Acinetobacter baumannii (AB). We adapted an existing osteomyelitis model to simulate an infected extremity wound for antibiotic testing. New Zealand White Rabbits (n = 95) were divided into 6 inoculation groups for infection with MRSA, KP, PA, and AB alone, and in multibacteria infections. Sodium morrhuate was injected into the left tibia to simulate blast wound trauma, then the respective bacteria or combination of pathogens, and finally sterile saline were injected. Colony-forming units for the mono-organism groups showed that AB, KP, or PA alone at 10 7 colony-forming units per ml (CFUs/mL) was effective for rabbit osteomyelitis induction. Colonyforming units for the multiorganism groups showed that the combination of AB (10 7 CFUs/mL)/KP (10 7 CFUs/mL)/PA (10 7 CFUs/mL)/MRSA (10 5 CFUs/mL) yielded a 100% osteomyelitis induction rate. At 8 weeks, however, only one mono-bacterial group and one multibacterial group showed significant radiographic improvement ( p < 0.05). The rabbit model of osteomyelitis can be adapted to study infected blast wounds typical of those seen in veterans. To our knowledge, this is the first demonstration of the model simulating multibacterial infections with multidrug-resistant organisms. INTRODUCTION The rabbit model for osteomyelitis, which has been used for decades and modified by dozens of researchers, has proved its effectiveness in the testing of novel antibiotics and therapy combinations to provide culture-directed treatment for infections. 1,2 However, the model has not been adapted to study the complications (multiple, resistant bacterial strains and wound necrosis) associated with trauma in general, or blast wounds in particular. In Afghanistan and Iraq, the military has an excellent record of providing rapid and highly advanced care aimed at fighting infection. However, a decrease in mortality rates because of the use of improved body armor and rapid evacuation in treatment has been accompanied by a substantial risk of developing infections with multidrug-resistant organisms (MDROs). One of the major challenges facing U.S. military caregivers is the presence of MDROs in orthopedic extremity wounds. 3,4 The most frequently identified resistant strains of bacteria in military and civilian hospitals are methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa (PA), Klebsiella pneumonia (KP), and Acinetobacter baumannii (AB). 5 9 We sought to advance the rabbit osteomyelitis model by using more relevant bacterial strains (AB, PA, KP, and MRSA) alone or in combinations and in a multi-infection model, all in the presence of wound necrosis. The study we Department of Orthopaedic Surgery, The Ohio State University Medical Center, 725 Prior Hall, 376 west 10th avenue, Columbus, OH 43210. All institutional and national guidelines for the care and use of laboratory animals were followed. All methods were approved and monitored for compliance to national standards by our institution s Animal Use and Care CommitteeandbytheAnimalCareand Use Review Office (ACURO), U.S. Army Medical Research and Materiel Command. doi: 10.7205/MILMED-D-12-00550 proposed will suggest to researchers a new pathway to study the antibiotic treatment of infection in necrotic wounds seen not only in battlefield environments but in other civilian trauma as well. MATERIALS AND METHODS All methods were approved and monitored for compliance to national standards by our institution s Animal Use and Care Committee and by the Animal Care and Use Review Office, U.S. Army Medical Research and Materiel Command. New Zealand White rabbits, 8 to 12 weeks old and weighing 2.0 to 3.5 kg, were used for this study. Strains of each pathogen were obtained from cultures of wounded veterans treated at Brooke Army Medical Center, Fort Sam Houston, Texas. After the rabbits underwent a minimum 7-day period of acclimatization, an 18-gauge needle was inserted percutaneously through the lateral aspect of the left tibial metaphysis into the intramedullary cavity under anesthesia, then 0.15 ml sodium morrhuate, infection bacteria (KP, AB, PA, and MRSA), and sterile saline were injected sequentially in five groups of 15 rabbits and one group of 20, organized into a total of 19 subgroups (n = 5) to simulate mono- and multiorganism infection (Table I). In the final group of rabbits (group 6), which was injected with all four pathogens, the dosage of sodium morrhuate was varied from 0.15 to 0.25 ml among the three subgroups to simulate different levels of damage to the tibia. Radiographs of tibias were taken at 2, 6, and 8 weeks. Rabbits were anesthetized with 0.6 mg PromACE/ ketamine (45 mg/kg) by subcutaneous injection before radiological testing. Radiographs were scored on a scale of 0 to 4+ by three investigators and the scores averaged (Fig. 1, Table II), a system we have described in previous studies of antibiotics. 10 12 The rabbits with radiographic scored 696

TABLE I. Rabbits Were Divided into Six Groups of 15 Animals Apiece Infection rate 8 weeks Groups Inoculation Titer (CFUs/mL) Marrow (Mean) Marrow (SD) Bone (Mean) Bone (SD) (%) 1 A AB (1 +10 5 )0.00E + 00 0.00E + 00 0.00E + 00 0.00E + 00 0.00 B AB (1 +10 7 )5.72E + 01 7.04E + 01 0.00E + 00 0.00E + 00 40.00 C AB (1 +10 8 )1.38E + 03 2.55E + 03 1.89E + 01 3.78E + 01 60.00 2 A PA (1 +10 5 )0.00E + 00 0.00E + 00 0.00E + 00 0.00E + 00 0.00 B PA (1 +10 7 )3.42E + 04 6.52E + 04 3.73E + 03 4.54E + 03 100.00 C PA (1 +10 8 )1.90E + 02 3.50E + 02 3.65E + 02 5.86E + 02 80.00 3 A KP (1 +10 5 )6.67E + 03 1.33E + 04 6.34E + 01 3.39E + 01 40.00 B KP ( 1 +10 7 )2.08E + 04 3.87E + 04 8.59E + 03 1.23E + 04 80.00 C KP (1 +10 8 )3.92E + 02 7.84E + 02 4.45E + 03 7.59E + 03 80.00 4 A AB (1 +10 8 ) + 0.00E + 00 0.00E + 00 0.00E + 00 0.00E + 000.00 B PA (1 +10 7 ) + 2.17E + 02 4.35E + 02 0.00E + 00 0.00E + 0020.00 C KP (1 +10 7 ) + 2.51E + 03 5.01E + 03 1.57E + 04 2.18E + 0460.00 5 A AB (1 +10 7 ) + PA (1 +10 7 ) + 2.82E + 04 5.10E + 04 4.18E + 05 8.19E + 05 100.00 B PA (1x10 7 ) + KP (1x10 7 ) + 1.12E + 04 2.18E + 04 7.50E + 04 9.41E + 04 60.00 C KP (1 +10 7 ) + AB (1 +10 7 ) + 6.13E + 05 1.23E + 06 1.12E + 07 2.23E + 07 40.00 D KP (1 +10 7 ) + AB (1 +10 7 ) + 2.83E + 02 4.64E + 02 5.17E + 05 9.04E + 05 100.00 PA (1 +10 7 ) 6 A KP (1 +10 7 ) + AB (1 +10 7 ) + 1.01E + 07 2.03E + 07 7.33E + 07 1.47E + 07 40.00 PA (1 +10 7 ) + : 0.15 ml Sodium Morrhuate B KP (1 +10 7 ) + AB (1 +10 7 ) + 4.24E + 02 6.33E + 02 1.48E + 05 2.15E + 05 100.00 PA (1 +10 7 ) + : 0.2 ml Sodium Morrhuate C KP (1 +10 7 ) + AB (1 +10 7 ) + 1.77E + 06 3.55E + 06 5.18E + 06 1.01E + 07 60.00 PA (1 +10 7 ) + : 0.25 ml Sodium Morrhuate Groups 1 to 3, simulated mono-bacterial infections. Groups 4 to 6, simulated multibacterial infections. Three subgroups (n = 5) were created in each group to test different inoculation levels (Groups 1 5) or to experiment with different concentrations of sodium morrhuate (Group 6). above Grade 2 were considered successful in induction of osteomyelitis. Rabbits were euthanized at 8 weeks. Left tibias were harvested from all rabbits. Concentrations of bacteria in bone matrix and bone marrow were determined. Marrow and the intramedullary canal of bilateral tibiae were swabbed with sterile cotton-tip applicators; inoculated applicators were streaked onto plates of Trypticase Soy Agar II supplemented with 5% (v/v) defibrinated sheep blood (BBL, Becton, Dickinson & Co., Sparks, Maryland) and then placed into tubes containing 5 ml of Trypticase Soy Broth (BBL). Plates and tubes were incubated at 37 C for 24 hours, and the presence or absence of growth in both media was recorded. Marrow from each rabbit tibia was deposited into sterile 50-mL centrifuge tubes and weighed. Matrix from each rabbit tibia was cut into 0.5 cm 2 chips, placed in sterile 50-mL centrifuge tubes, and weighed. Physiological saline was added at a ratio of 3 ml of saline per gram FIGURE 1. Representative lateral X-rays of Grades 0 to 4 in radiographic scoring system, with Grade 0 representing no infection and Grade 4 representing highest level of infection. Each representative image of a left tibia received unanimous score from graders: A, Grade 0 (normal); B, Grade 1, shows elevation of periosteum (arrow); C, Grade 2, <10% disruption of normal bone architecture (arrow); D, Grade 3, 10 to 40% disruption of bone architecture (arrow); E, Grade 4, >40% disruption, entire tibia compromised (circle). 697

TABLE II. Radiographic Grading Grade a Description of Changes 0 Normal, No Change Compared With Right Tibia 1+ Elevation or Disruption of Periosteum, or Both; Soft Tissue Swelling 2+ <10% Disruption of Normal Bone Architecture 3+ 10 40% Disruption of Normal Bone Architecture 4+ >40% Disruption of Normal Bone Architecture a Visually estimated percentage of disrupted bone. TABLE III. Radiographic Scores for the Mono-Bacterial War Wound Groups Demonstrating That Only One Group (2A) Showed Significant Improvement at 8 Weeks Groups Inoculation Titer (CFUs/mL) 2 weeks 6 weeks 8 weeks 1 A AB (1 +10 5 ) 0.8 ± 0.7 1.5 ± 1.1 1.0 ± 1.3 B AB (1 +10 7 ) 0.9 ± 0.5 1.1 ± 0.6 0.3 ± 0.4 C AB (1 +10 8 ) 1.7 ± 1.0 1.1 ± 0.6 0.8 ± 0.7 2 A PA (1 +10 5 ) 1.4 ± 0.1 1.4 ± 0.4 0 ± 0 B PA (1 +10 7 ) 2.4 ± 0.8a 2.7 ± 0.7a 1.7 ± 1.4 C PA (1 +10 8 ) 1.7 ± 0.1 2.2 ± 1.0a 1.7 ± 0.4 3 A KP (1 +10 5 ) 1.7 ± 0.2 1.1 ± 0.6 1.0 ± 0.8 B KP (1 +10 7 ) 2.5 ± 0.6a 2.4 ± 1.5a 3.2 ± 1.2a C KP (1 +10 8 ) 3.1 ± 1.6a 3.2 ± 1.6a 3.4 ± 1.2a a Radiographic score was greater than 2. of bone matrix or marrow. Bone matrix and marrow suspensions were vortexed for 2 minutes and serially diluted with sterile physiological saline; 20 ml aliquots were plated onto blood agar, incubated at 37 C, and colonies counted after 24 hours. The limit of detection for viable counts was 50 colony-forming units per ml (CFUs/mL), corresponding to 150 CFUs/g of bone matrix and 200 CFUs/g of marrow. Means ± standard deviations were calculated and a twoway analysis of variance was used to determine whether there were significant differences in radiographical scoring or bacterial counts in matrix and marrow from left tibiae in rabbits from different groups. Differences between groups were deemed statistically significant if p 0.05. RESULTS Bacteria load and clearance rates for all groups are shown in Table I. Colony-forming units per gram of marrow and bone for the mono-organism groups show that AB, KP, or PA alone at 10 7 CFUs/mL was effective for rabbit osteomyelitis induction. Colony-forming units per gram of marrow and bone for the multibacterial groups show that the combination of AB (10 7 CFUs/mL)/KP (10 7 CFUs/mL)/PA (10 7 CFUs/mL)/MRSA (10 5 CFUs/mL) with 0.2 ml sodium morrhuate yielded a 100% osteomyelitis induction rate in our study. Radiographic results reflect the rate and extent of bone reconstruction and remodeling, which in osteomyelitis usually lags behind bacterial clearance. 13 Two weeks, radiographic scores for all mono-infection groups were varied (Table III). By 8 weeks, only one monoinfection group, PA (1 +10 5 CFUs/mL), showed significant radiographic improvement ( p < 0.05). For multibacterial osteomyelitis models, radiographic scores (Table IV) for six of the 10 groups were greater than Grade 2. By 8 weeks, however, only 1 group (KP [1 +10 7 CFUs/mL] + AB [1 +10 7 CFUs/mL] + PA [1 10 7 CFUs/mL] + MRSA [1 +10 5 CFUs/mL]) showed significant radiographic improvement ( p < 0.05). There were no adverse events. Of the 95 rabbits infected, none died before completion of treatment. All rabbits gained weight and tolerated the development of the severe tibial bone infection. DISCUSSION We proposed to adapt the existing rabbit model for the induction of osteomyelitis to simulate infection in trauma seen in U.S. military personnel from recent conflicts, particularly blast wounds to the extremities. This adaptation would offer the possibility of more accurately simulating the challenge of treating these wounds with available antibiotics or combinations of antibiotics. Our study has limitations typical of the established rabbit model. They are the possibility of self-recovery because of + TABLE IV. Radiographic Scores for the Multibacterial War Wound Groups Demonstrating That Only One Group (5A) Showed Significant Improvement at 8 Weeks Groups Inoculation Titer (CFUs/mL) 2 weeks 6 weeks 8 weeks 4 A AB (1 +10 8 ) + 2.0 ± 0.4a 0.9 ± 0.9 0.5 ± 0.4 B PA (1 +10 7 ) + 1.5 ± 0.6 1.0 ± 0.7 1.3 ± 0.7 C KP (1 +10 7 ) + 1.8 ± 0.7 2.5 ± 1.3a 1.0 ± 1.1 5 A AB (1 +10 7 ) + PA (1 +10 7 ) + 2.1 ± 0.4a 2.9 ± 1.6a 1.9 ± 0.8 B PA (1 +10 7 ) + KP (1 +10 7 ) + 1.8 ± 0.3 3.5 ± 0.7a 2.1 ± 0.8a C KP (1 +10 7 ) + AB (1 +10 7 ) + 2.2 ± 1.1a 1.9 ± 1.4 1.5 ± 0.6 D KP (1 +10 7 ) + AB (1 +10 7 ) + PA (1 +10 7 )2.4 ± 0.4a 1.5 ± 1.4 2.1 ± 1.1a 6 A KP (1x10 7 ) + AB (1 +10 7 ) + PA (1 +10 7 ) + 2.5 ± 0.9a 2.4 ± 1.2a 2.3 ± 1.3a B KP (1 +10 7 ) + AB (1 +10 7 ) + PA (1 +10 7 ) + 2.9 ± 0.6a 2.3 ± 1.5a 1.5 ± 0.9 C KP (1 +10 7 ) + AB (1 +10 7 ) + PA (1 +10 7 ) + 2.7 ± 1.4a 1.5 ± 1.22.7 ± 1.2a a Radiographic score was greater than 2. 698

animal immunity and infection to other sites or systemic sepsis because of the bacteremia. However, our subjects did not experience either problem. Although our study was sufficient in number of subjects to yield statistically significant results in radiographic scoring, we acknowledge that larger sample sizes will be needed to investigate further differences among treatment groups. Finally, our study did not use a true control or sham group of rabbits injected only with sodium morrhuate and no bacterial pathogen. In this regard, it should be noted that Scheman in 1941, using a 23-gauge needle and 0.3 to 0.4 ccs of sodium morrhuate, first showed that sodium morrhuate could produce either aseptic necrosis (when used alone) or osteomyelitis (when bacteria were also introduced) in the rabbit. 14 Norden, in 1970, further showed that animals injected with sodium morrhuate alone did not have pathologic evidence or cultures of osteomyelitis after 14 or 60 days, and that both bone necrosis (or the introduction of an implant, such as an intramedullary pin) and a bacterial pathogen were required to create an infection in the laboratory rabbit. 15 Although our model does not expose the rabbits to the level of trauma that is often seen in the field of battle, the use of sodium morrhuate simulates the necrosis that is often observed in war wounds. 16 Sodium morrhuate is a sclerosing agent that has been used in other rabbit studies to simulate damage to tissues such as cartilage and tendons. 17,18 It is also used in various animal models of infection, 19 23 including traumatic infection, 24 although researchers who are not studying trauma typically may prefer to use devascularized bone 25 or more likely an implant 26 to reliably produce the infections required to test antibiotics in animals. Although our study does not use an implant, the presence of surrounding tissue necrosis in war wounds complicates treatment for infection, and this is compounded further when multiple strains of bacteria are present. The rabbit osteomyelitis models developed by previous researchers were designed for a monobacterial approach, which can be treated by single or combined antibiotic therapy. 1,2,15,26 30 We have shown a method to broaden the model to study multibacterial infections. The data show that AB, KP, or PA alone at 10 7 CFUs/mL was effective for rabbit osteomyelitis induction. The different combinations of MDROs were more effective in osteomyelitis induction. The combination of AB (10 7 CFUs/mL)/KP (10 7 CFUs/mL)/PA (10 7 CFUs/mL)/MRSA (10 5 CFUs/mL) with 0.2 ml sodium morrhuate yielded 100% osteomyelitis induction rate in our pilot study. The radiographic images showed all stages of osteomyelitis as that of human infection. All the rabbits gained weight and tolerated the severe tibial infection by multiple drug resistant organisms. Our results suggest that AB, PA, or KP alone, or in combinations including MRSA was effective in the development of MDRO-induced war wound rabbit osteomyelitis. Such an animal model could be reliably reproducible in large numbers. We have initiated larger animal trials to examine the efficacy of single antibiotics or antibiotic combinations, including tigecycline, daptomycin, and vancomycin, to determine which treatment regimen is most effective in eradicating MDRO infections in this model. ACKNOWLEDGMENTS The authors acknowledge Clinton K. Murray, MD, Brooke Army Med Center, Fort Sam Houston, Texas, for assistance in obtaining bacterial samples, and Stephen McConoughey, PhD, and Randy Roberts of The Ohio State University for their assistance in preparing this manuscript. The authors acknowledge funding by the U.S. Department of Defense and the U.S. Army Institute of Surgical Research Orthopaedic Trauma Research Program. REFERENCES 1. Mader JT: Animal models of osteomyelitis. Am J Med 1985; 78(6B): 213 7. 2. Mader JT, Shirtliff ME: The rabbit model of bacterial osteomyelitis. In: Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy, pp 581 91. Edited by Sande MA, Zak O. London, Academic Press, 1999. 3. Murray CK: Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan. J Trauma 2008; 64(3 Suppl): S232 8. 4. Fishbain JT, Carneiro C, Ewell A: Antimicrobial Resistance Patterns and Treatment Challenges in Isolates from Operation Enduring Freedom and Operation Iraqi Freedom. Extremity War Injuries: State of the Art and Future Directions. Washington, DC, Office of the Surgeon General, Department of the Army, 2006. 5. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO: In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2006; 27(3): 224 8. 6. Grover SS, Sharma M, Pasha ST, Singh G, Lal S: Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi. J Commun Dis 2004; 36(1): 17 26. 7. Campbell KM, Vaughn AF, Russell KL, et al: Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 2004; 42(9): 4050 3. 8. Beilman GJ, Sandifer G, Skarda D, et al: Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an Army Community Hospital. Surg Infect (Larchmt) 2005; 6(1): 87 92. 9. Calhoun JH, Murray CK, Manring MM: Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res 2008; 466(6): 1356 62. 10. Yin LY, Calhoun JH, Thomas TS, Wirtz ED: Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model. J Antimicrob Chemother 2009; 63(2): 357 60. 11. Yin LY, Calhoun JH, Thomas JK, Shapiro S, Schmitt-Hoffmann A: Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52(5): 1618 22. 12. Yin LY, Lazzarini L, Li F, Stevens CM, Calhoun JH: Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 2005; 55(6): 995 1002. 13. Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am 2005; 19(4): 765 86. 699

14. Scheman L, Janota J, Lewin P: The production of experimental osteomyelitis: preliminary report. J Am Med Assoc 1941; 117(18): 1525 9. 15. Norden CW: Experimental osteomyelitis. I. A description of the model. J Infect Dis 1970; 122(5): 410 8. 16. Kozarski J, Cvetanovic S, Gacevic M, Vesanovic S: Treatment of the war wounds of the hand. Facta Univ 2008; 15(2): 56 68. 17. Liu YK, Tipton CM, Matthes RD, Bedford TG, Maynard JA, Walmer HC: An in situ study of the influence of a sclerosing solution in rabbit medial collateral ligaments and its junction strength. Connect Tissue Res 1983; 11(2 3): 95 102. 18. Maynard JA, Pedrini VA, Pedrini-Mille A, Romanus B, Ohlerking F: Morphological and biochemical effects of sodium morrhuate on tendons. J Orthop Res 1985; 3(2): 236 48. 19. Mayberry-Carson KJ, Tober-Meyer B, Smith JK, Lambe DW Jr, Costerton JW: Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus. Infect Immun 1984; 43(3): 825 33. 20. Salgado CJ, Jamali AA, Mardini S, Buchanan K, Veit B: A model for chronic osteomyelitis using Staphylococcus aureus in goats. Clin Orthop Relat Res 2005; 436(436): 246 50. 21. Hienz SA, Sakamoto H, Flock JI, et al: Development and characterization of a new model of hematogenous osteomyelitis in the rat. J Infect Dis 1995; 171(5): 1230 6. 22. Steinhart H, Schulz S, Mutters R: Evaluation of ozonated oxygen in an experimental animal model of osteomyelitis as a further treatment option for skull-base osteomyelitis. Eur Arch Otorhinolaryngol 1999; 256(3): 153 7. 23. Rissing JP, Buxton TB, Weinstein RS, Shockley RK: Model of experimental chronic osteomyelitis in rats. Infect Immun 1985; 47(3): 581 6. 24. Calabro L, Lutton C, El Din AFS, Richards RG, Moriarty TF: Animal models of orthopedic implant-related infection. In: Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies, pp 273 304. Edited by Moriarty TF, Zaat SAJ, Busscher JJ. New York, Springer, 2013. 25. Smeltzer MS, Thomas JR, Hickmon SG, et al: Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res 1997; 15(3): 414 21. 26. Andriole VT, Nagel DA, Southwick WO: A paradigm for human chronic osteomyelitis. J Bone Joint Surg Am 1973; 55(7): 1511 5. 27. Johansson A, Svensson O, Blomgren G, Eliasson G, Nord CE: Anaerobic osteomyelitis. A new experimental rabbit model. Clin Orthop Relat Res 1991; 265: 297 301. 28. Rodeheaver GT, Rukstalis D, Bono M, Bellamy W: A new model of bone infection used to evaluate the efficacy of antibiotic-impregnated polymethylmethacrylate cement. Clin Orthop Relat Res 1983; 178: 303 11. 29. Sanzen L, Linder L: Infection adjacent to titanium and bone cement implants: an experimental study in rabbits. Biomaterials 1995; 16(16): 1273 7. 30. Eerenberg JP, Patka P, Haarman HJ, Dwars BJ: A new model for posttraumatic osteomyelitis in rabbits. J Invest Surg 1994; 7(5): 453 65. 700